SFX by Ex Libris Inc.

Title:	CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Source:	Nature [0028-0836] Shiow, Lawrence yr:2006

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Sánchez-Madrid, F. "CD69 is an immunoregulatory molecule induced following activation." Trends in immunology 26.3 (2005): 136-40.
description	2.	Bankovich, Alexander G. "CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4." Journal of biological chemistry 285.29 (2010): 22328-22337.
description	3.	Coelho, Rochelle P P. "The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors." The Journal of pharmacology and experimental therapeutics 323.2 (2007): 626-35.
description	4.	Fogel, Amy J. "Regulation of T Cell Responses in the Developing Human Fetus." The journal of immunology 176.10 (2006): 5741-5748.
description	5.	Nolte-'t Hoen, E. "Effector and regulatory T cells derived from the same T cell clone differ in MHC class II-peptide multimer binding." European journal of immunology 34.12 (2004): 3359-3369.
description	6.	Testi, R. "The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells." Immunology today 15.10 (1994): 479-83.
description	7.	Llera, A S S. "Crystal structure of the C-type lectin-like domain from the human hematopoietic cell receptor CD69." The Journal of biological chemistry 276.10 (2001): 7312-9.
description	8.	Libby, P. "Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis." The American journal of pathology 172.6 (2008): 1500-8.
description	9.	Lefrançois, Leo S. "Cytokine control of memory T-cell development and survival." Nature reviews. Immunology 3.4 (2003): 269-79.
description	10.	Cyster, Jason G. "Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs." Annual review of immunology 30.1 (2012): 69-94.
description	11.	Hsu, F. "NKAP is required for T cell maturation and acquisition of functional competency." The Journal of experimental medicine 208.6 (2011): 1291-1304.
description	12.	Miron, Veronique E. "FTY720 modulates human oligodendrocyte progenitor process extension and survival." Annals of neurology 63.1 (2008): 61-71.
description	13.	Zoetis, Kenneth S S. "Species comparison of anatomical and functional renal development." Birth defects research. Part B, Developmental and reproductive toxicology 68.2 (2003): 111-20.
description	14.	Foster, Carolyn A. "Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis." The Journal of pharmacology and experimental therapeutics 323.2 (2007): 469-476.
description	15.	Bible, E. "Multiple sclerosis: Drug-enhanced remyelination in a multiple sclerosis model." Nature reviews. Neurology 9.12 (2013): 660-660.
description	16.	Koehler, S. "A family of variably expressed outer-membrane proteins (Vomp) mediates adhesion and autoaggregation in Bartonella quintana." Proceedings of the National Academy of Sciences of the United States of America 101.37 (2004): 13630-5.
description	17.	Lee, Hyun-Hee H. "Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity." The Journal of experimental medicine 205.10 (2008): 2269-80.
description	18.	Brinkmann, V. "Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology." Pharmacology & therapeutics 115.1 (2007): 84-105.
description	19.	Agbayani-Siewert, P. "Ultrasound's new phase." Scientific American 274.6 (1996): 32-.
description	20.	Dietl, J. "Natural killer cells and dendritic cells at the human feto-maternal interface: an effective cooperation?" Placenta 27.4-5 (2006): 341-7.